And their regulatory footprints could hardly be more different: as of mid-2026 tirzepatide is an approved medicine on two continents, while CagriSema has completed its pivotal Phase 3a program but is not approved by any regulator
BPC-157 - A Research Peptide Investigated for Vascular Support and Tissue Regeneration BPC-157 is a synthetic peptide derived from the naturally occurring Body Protection Compound , originally identified in human gastric juice
Tri-Fortify Liposomal Glutathione (48 servings) Tri-Fortify is a clinically researched liposomal glutathione in a delicious oral delivery system, providing superior cellular absorption
Discovering knee osteoarthritis imaging features for diagnosis and prognosis: review of manual imaging grading and machine learning approaches
TABLE 1 Comparison of programmed cell death modes
This is part of what makes peptides so appealing compared to typical pharmaceuticals: Many of the most common peptides used for medicinal purposes today (like for weight loss, diabetes, and hormone issues) are sequenced directly from peptides in our bodies
